BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25.09.2025

FDA Announces Draft Guidance for Capturing Safety and Efficacy Data for Cell and Gene Therapy Products

The FDA has released a draft document outlining methods for collecting postapproval safety and efficacy data for cell and gene therapy products, given their potential for long-lasting effects and limited clinical trial participant numbers.

Source: Federal Register — Food and Drug AdministrationOpen original release →